Liver resection should be the primary therapeutic option for patients with early multinodular hepatocellular carcinoma (HCC) who are ineligible for transplant, a retrospective cohort study suggested.

For patients with early multinodular hepatocellular carcinoma (HCC) who are ineligible for liver transplant, liver resection provides a survival advantage over percutaneous radiofrequency ablation and ...

Laparoscopic surgery led to a substantial reduction in functional recovery time and postoperative hospital stay compared with open surgery in patients undergoing parenchyma-preserving resection of ...

Previous reports have also described the safety of resecting segments 7 and 8. However, they drew conclusions on smaller cohorts than our present study, and some included segments 1, 4a, 7, and 8, ...

Platelet count at baseline (Plt) and outcomes in patients (pts) with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S) in CALGB80802 (Alliance) (C8). This is an ASCO Meeting Abstract ...

Hepatocellular carcinoma (HCC) is an aggressive malignancy of the liver that most often arises in patients with cirrhosis and other chronic liver diseases. Worldwide, it is the sixth most common ...

Histotripsy is a new, FDA-approved, minimally invasive technique that destroys liver tumors using high-frequency ultrasound waves. For some patients with liver cancer, they could be spared invasive ...

It’s well known that the liver is the only organ in the human body that can regenerate. Sometimes, the renewal process fails, and a transplant is required. Researchers have now discovered why this ...

A new blood test may help detect liver cancer earlier in people with chronic liver disease, potentially improving access to ...

A new study has found that MET (hepatocyte growth factor receptor) signaling plays a critical protective role in acetaminophen-induced acute liver failure (ALF). This pathway is shown to work as a ...